Integrated Health Care for PTSD

NCT07220681 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-01-07

No results posted yet for this study

Summary

The goal of this clinical trial is to determine whether which types of integrative care, meaning a combination of psychotherapy and mind-body interventions, lead to the most changes in functioning among Veterans with posttraumatic stress disorder (PTSD). The main aims are:

1. To evaluate the impact of integrative care approaches on functional outcomes among Veterans with PTSD.
2. To examine factors relevant to the implementation of integrated treatments for PTSD from the perspective of patients, providers and administrators in the VA Healthcare System.

Participants will:

1. Complete assessments at the beginning of the study and 12- and 24-weeks later.
2. Engage in 12 weeks of integrated care, with the type being randomly assigned.

Conditions

  • Posttraumatic Stress Disorder (PTSD)

Interventions

BEHAVIORAL

Yoga and meditation

12 weekly 60-minute hatha yoga classes and access to video-based training in a portable mantra-based meditation practice

BEHAVIORAL

Wellness

12 weekly 60-minute classes to provide education about exercise and nutrition and facilitate lifestyle changes

BEHAVIORAL

Positive affect

12 weekly 60-minute classes to teach strategies for increasing positive affect and to provide social connection

OTHER

Information

Provision of written information about local and national complementary and integrative care resources

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • Veterans Medical Research Foundation

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-05
Primary Completion
2029-06-30
Completion
2029-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07220681 on ClinicalTrials.gov